Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
A phase 3 trial of Cetuximab, Floxuridine, Fluorouracil, Irinotecan, Leucovorin, Oxaliplatin and Panitumumab in Colorectal cancer, run by ECOG-ACRIN Cancer Research Group, now recruiting.
Overview
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial is a phase 3 interventional study registered as NCT05863195 by ECOG-ACRIN Cancer Research Group, with 408 participants planned, started 2023-10-19 and due to reach its primary completion in 2029-06-30. Interventions recorded: Bevacizumab, Cetuximab, Computed Tomography, Floxuridine, Fluorouracil, Implantation, Intrahepatic Infusion Procedure, Irinotecan, Leucovorin, Oxaliplatin, Panitumumab, Single Photon Emission Computed Tomography. Conditions recorded: Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver, Stage IV Colorectal Cancer AJCC v8, Unresectable Colorectal Carcinoma.
Linked to the drug Floxuridine because the registry names it among its interventions and Colorectal cancer among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialFUDR/Oxaliplatin HAI Plus Irinotecan vs. FOLFOXIRI Chemotherapy in Treating Initially Unresectable CRCLM
Shares Floxuridine, Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Oxaliplatin and the tag pipeline.
- TrialCombination Chemotherapy and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialOxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Shares Floxuridine, Oxaliplatin, Colorectal cancer and the tag pipeline.
- TrialG-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialA Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin, Cetuximab, Colorectal cancer and the tag pipeline.
- TrialCediranib (AZD2171, RECENTIN™) in Addition to Chemotherapy in Patients With Untreated Metastatic Colorectal Cancer
Shares Leucovorin (folinic acid), Oxaliplatin, Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialPalliative Chemotherapy in Treating Patients With Advanced Colorectal Cancer
Shares Leucovorin (folinic acid), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.
- TrialA Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in Japan
Shares Irinotecan (and liposomal irinotecan), Fluorouracil (5-FU), Colorectal cancer and the tag pipeline.